Clinical trial
Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients
NCT00651612 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients
- Lead sponsor
- Allergan
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2005
- Completion date
- January 31, 2007
- Enrollment
- 604 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.